[Advanced carcinoma of the prostate (stages C and D). Mortality within 12 months of the initiation of hormonal therapy]. / Carcinoma avanzato della prostata (stadi C e D). Mortalità entro 12 mesi dall'inizio della terapia ormonale.
Minerva Urol Nefrol
; 44(3): 205-8, 1992.
Article
em It
| MEDLINE
| ID: mdl-1492272
ABSTRACT
Seventy-three patients with stage C and D prostatic carcinoma were treated with hormonotherapy. During a mean follow-up of 27 +/- 17.8 months, 30 tumour-related deaths were registered. The patients in the G3 subset suffered a 35.7% early death rate versus a 10.1% rate of G1-2 ones. This difference is significant (p = 0.0102). Nevertheless the Authors' opinion is that G3 patients should not be given a more aggressive treatment initially apart from the case of a controlled trial.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Próstata
/
Carcinoma
/
Gosserrelina
/
Flutamida
Idioma:
It
Ano de publicação:
1992
Tipo de documento:
Article